Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Fresenius Medical Care, listed under the ticker FME, is a global provider of dialysis services and products for individuals diagnosed with chronic kidney failure. Founded in 1996 and headquartered in Bad Homburg, Germany, the company operates in the healthcare sector. Beyond dialysis, Fresenius Medical Care offers a range of other services, including hospital management and related healthcare services, advancing its position as a comprehensive healthcare provider internationally.
View stock
VS
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
View stock

Stock highlights

Stock comparison highlights
Stock name
Fresenius Medical Care AGAbbVie
Last price
€37.91$279.81
Currency
EUR
USD
€9.9B$489B
11.2478.11
€3.35$3.54
0.830.28
€1.49$6.83
3.96%2.50%
Sector
HealthHealth
Employees
107,22657,000
Ticker
€FME$ABBV
Primary listing
XETRANYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €FME or $ABBV on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.